[
    {
      "title": "Thomas C. Sudhof",
      "text": "Introduction\nThomas Christian Sudhof (German pronunciation: ['to:mas 'zy:t,ho:f] i; born December 22, 1955), ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.",
      "idx": 0
    },
    {
      "title": "David Eagleman",
      "text": "Introduction\nDavid Eagleman (born April 25, 1971) is an American neuroscientist, author, and science communicator. He teaches neuroscience at Stanford University[1] and is CEO and co-founder of Neosensory, a company that develops devices for sensory substitution. [2] He also directs the non-profit Center for Science and Law, which seeks to align the legal system with modern neuroscience[3] and is Chief Science Officer and co-founder of BrainCheck, a digital cognitive health platform used in medical practices and health systems.",
      "idx": 1
    },
    {
      "title": "Karl Deisseroth",
      "text": "Introduction\nKarl Alexander Deisseroth (born November 18, 1971) is an American scientist. He is the D.H. Chen Foundation Professor of Bioengineering and of psychiatry and behavioral sciences at Stanford University. He is known for creating and developing the technologies of hydrogel-tissue chemistry (e.g., CLARITY, STARmap) and optogenetics, and for applying integrated optical and genetic strategies to study normal neural circuit function, as well as dysfunction in neurological and psychiatric disease.",
      "idx": 2
    },
    {
      "title": "Thomas C. Sudhof",
      "text": "Career and research\nSudhof's research has not only given the scientific community a great understanding of the processes underlying synaptic transmission and synapse formation, but has also advanced medical knowledge of mechanisms behind poorly understood diseases such as Alzheimer's, Schizophrenia, and Autism. He is currently working with a diverse group of researchers at the Howard Hughes Medical Institute to develop mouse models for mutants of synaptic genes.",
      "idx": 3
    },
    {
      "title": "Thomas C. Sudhof",
      "text": "Introduction\nThomas Christian Sudhof (German pronunciation: ['to:mas 'zy:t,ho:f] i; born December 22, 1955), ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.",
      "idx": 4
    },
    {
      "title": "David Eagleman",
      "text": "Introduction\nDavid Eagleman (born April 25, 1971) is an American neuroscientist, author, and science communicator. He teaches neuroscience at Stanford University[1] and is CEO and co-founder of Neosensory, a company that develops devices for sensory substitution. [2] He also directs the non-profit Center for Science and Law, which seeks to align the legal system with modern neuroscience[3] and is Chief Science Officer and co-founder of BrainCheck, a digital cognitive health platform used in medical practices and health systems.",
      "idx": 5
    },
    {
      "title": "Karl Deisseroth",
      "text": "Introduction\nKarl Alexander Deisseroth (born November 18, 1971) is an American scientist. He is the D.H. Chen Foundation Professor of Bioengineering and of psychiatry and behavioral sciences at Stanford University. He is known for creating and developing the technologies of hydrogel-tissue chemistry (e.g., CLARITY, STARmap) and optogenetics, and for applying integrated optical and genetic strategies to study normal neural circuit function, as well as dysfunction in neurological and psychiatric disease.",
      "idx": 6
    },
    {
      "title": "Thomas C. Sudhof",
      "text": "Career and research\nSudhof's research has not only given the scientific community a great understanding of the processes underlying synaptic transmission and synapse formation, but has also advanced medical knowledge of mechanisms behind poorly understood diseases such as Alzheimer's, Schizophrenia, and Autism. He is currently working with a diverse group of researchers at the Howard Hughes Medical Institute to develop mouse models for mutants of synaptic genes.",
      "idx": 7
    },
    {
      "title": "Thomas C. Sudhof",
      "text": "Introduction\nThomas Christian Sudhof (German pronunciation: ['to:mas 'zy:t,ho:f] i; born December 22, 1955), ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.",
      "idx": 8
    },
    {
      "title": "David Eagleman",
      "text": "Introduction\nDavid Eagleman (born April 25, 1971) is an American neuroscientist, author, and science communicator. He teaches neuroscience at Stanford University[1] and is CEO and co-founder of Neosensory, a company that develops devices for sensory substitution. [2] He also directs the non-profit Center for Science and Law, which seeks to align the legal system with modern neuroscience[3] and is Chief Science Officer and co-founder of BrainCheck, a digital cognitive health platform used in medical practices and health systems.",
      "idx": 9
    },
    {
      "title": "Karl Deisseroth",
      "text": "Introduction\nKarl Alexander Deisseroth (born November 18, 1971) is an American scientist. He is the D.H. Chen Foundation Professor of Bioengineering and of psychiatry and behavioral sciences at Stanford University. He is known for creating and developing the technologies of hydrogel-tissue chemistry (e.g., CLARITY, STARmap) and optogenetics, and for applying integrated optical and genetic strategies to study normal neural circuit function, as well as dysfunction in neurological and psychiatric disease.",
      "idx": 10
    },
    {
      "title": "Thomas C. Sudhof",
      "text": "Career and research\nSudhof's research has not only given the scientific community a great understanding of the processes underlying synaptic transmission and synapse formation, but has also advanced medical knowledge of mechanisms behind poorly understood diseases such as Alzheimer's, Schizophrenia, and Autism. He is currently working with a diverse group of researchers at the Howard Hughes Medical Institute to develop mouse models for mutants of synaptic genes.",
      "idx": 11
    },
    {
      "title": "Thomas C. Sudhof",
      "text": "Introduction\nThomas Christian Sudhof (German pronunciation: ['to:mas 'zy:t,ho:f] i; born December 22, 1955), ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.",
      "idx": 12
    },
    {
      "title": "David Eagleman",
      "text": "Introduction\nDavid Eagleman (born April 25, 1971) is an American neuroscientist, author, and science communicator. He teaches neuroscience at Stanford University[1] and is CEO and co-founder of Neosensory, a company that develops devices for sensory substitution. [2] He also directs the non-profit Center for Science and Law, which seeks to align the legal system with modern neuroscience[3] and is Chief Science Officer and co-founder of BrainCheck, a digital cognitive health platform used in medical practices and health systems.",
      "idx": 13
    },
    {
      "title": "Karl Deisseroth",
      "text": "Introduction\nKarl Alexander Deisseroth (born November 18, 1971) is an American scientist. He is the D.H. Chen Foundation Professor of Bioengineering and of psychiatry and behavioral sciences at Stanford University. He is known for creating and developing the technologies of hydrogel-tissue chemistry (e.g., CLARITY, STARmap) and optogenetics, and for applying integrated optical and genetic strategies to study normal neural circuit function, as well as dysfunction in neurological and psychiatric disease.",
      "idx": 14
    },
    {
      "title": "Thomas C. Sudhof",
      "text": "Career and research\nSudhof's research has not only given the scientific community a great understanding of the processes underlying synaptic transmission and synapse formation, but has also advanced medical knowledge of mechanisms behind poorly understood diseases such as Alzheimer's, Schizophrenia, and Autism. He is currently working with a diverse group of researchers at the Howard Hughes Medical Institute to develop mouse models for mutants of synaptic genes.",
      "idx": 15
    },
    {
      "title": "Thomas C. Sudhof",
      "text": "Introduction\nThomas Christian Sudhof (German pronunciation: ['to:mas 'zy:t,ho:f] i; born December 22, 1955), ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.",
      "idx": 16
    },
    {
      "title": "David Eagleman",
      "text": "Introduction\nDavid Eagleman (born April 25, 1971) is an American neuroscientist, author, and science communicator. He teaches neuroscience at Stanford University[1] and is CEO and co-founder of Neosensory, a company that develops devices for sensory substitution. [2] He also directs the non-profit Center for Science and Law, which seeks to align the legal system with modern neuroscience[3] and is Chief Science Officer and co-founder of BrainCheck, a digital cognitive health platform used in medical practices and health systems.",
      "idx": 17
    },
    {
      "title": "Karl Deisseroth",
      "text": "Introduction\nKarl Alexander Deisseroth (born November 18, 1971) is an American scientist. He is the D.H. Chen Foundation Professor of Bioengineering and of psychiatry and behavioral sciences at Stanford University. He is known for creating and developing the technologies of hydrogel-tissue chemistry (e.g., CLARITY, STARmap) and optogenetics, and for applying integrated optical and genetic strategies to study normal neural circuit function, as well as dysfunction in neurological and psychiatric disease.",
      "idx": 18
    },
    {
      "title": "Thomas C. Sudhof",
      "text": "Career and research\nSudhof's research has not only given the scientific community a great understanding of the processes underlying synaptic transmission and synapse formation, but has also advanced medical knowledge of mechanisms behind poorly understood diseases such as Alzheimer's, Schizophrenia, and Autism. He is currently working with a diverse group of researchers at the Howard Hughes Medical Institute to develop mouse models for mutants of synaptic genes.",
      "idx": 19
    },
    {
      "title": "Thomas C. Sudhof",
      "text": "Introduction\nThomas Christian Sudhof (German pronunciation: ['to:mas 'zy:t,ho:f] i; born December 22, 1955), ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.",
      "idx": 20
    },
    {
      "title": "David Eagleman",
      "text": "Introduction\nDavid Eagleman (born April 25, 1971) is an American neuroscientist, author, and science communicator. He teaches neuroscience at Stanford University[1] and is CEO and co-founder of Neosensory, a company that develops devices for sensory substitution. [2] He also directs the non-profit Center for Science and Law, which seeks to align the legal system with modern neuroscience[3] and is Chief Science Officer and co-founder of BrainCheck, a digital cognitive health platform used in medical practices and health systems.",
      "idx": 21
    },
    {
      "title": "Karl Deisseroth",
      "text": "Introduction\nKarl Alexander Deisseroth (born November 18, 1971) is an American scientist. He is the D.H. Chen Foundation Professor of Bioengineering and of psychiatry and behavioral sciences at Stanford University. He is known for creating and developing the technologies of hydrogel-tissue chemistry (e.g., CLARITY, STARmap) and optogenetics, and for applying integrated optical and genetic strategies to study normal neural circuit function, as well as dysfunction in neurological and psychiatric disease.",
      "idx": 22
    },
    {
      "title": "Thomas C. Sudhof",
      "text": "Career and research\nSudhof's research has not only given the scientific community a great understanding of the processes underlying synaptic transmission and synapse formation, but has also advanced medical knowledge of mechanisms behind poorly understood diseases such as Alzheimer's, Schizophrenia, and Autism. He is currently working with a diverse group of researchers at the Howard Hughes Medical Institute to develop mouse models for mutants of synaptic genes.",
      "idx": 23
    }
  ]